Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease

Behçet's disease (BD) and vitiligo are diseases of unknown etiology. Interferon (IFN) alpha therapy is commonly used in Behçet uveitis. Interferon treatment in various diseases have also been observed causing certain autoimmune diseases such as vitiligo because of its immunomodulatory activity....

Descripción completa

Detalles Bibliográficos
Autores principales: Guney, Esra, Akcali, Gulunay, Akcay, Betul Ilkay, Unlu, Cihan, Erdogan, Gurkan, Bozkurt, Tahir Kansu, Bayramlar, Huseyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431079/
https://www.ncbi.nlm.nih.gov/pubmed/22952476
http://dx.doi.org/10.1155/2012/387140
_version_ 1782242025466232832
author Guney, Esra
Akcali, Gulunay
Akcay, Betul Ilkay
Unlu, Cihan
Erdogan, Gurkan
Bozkurt, Tahir Kansu
Bayramlar, Huseyin
author_facet Guney, Esra
Akcali, Gulunay
Akcay, Betul Ilkay
Unlu, Cihan
Erdogan, Gurkan
Bozkurt, Tahir Kansu
Bayramlar, Huseyin
author_sort Guney, Esra
collection PubMed
description Behçet's disease (BD) and vitiligo are diseases of unknown etiology. Interferon (IFN) alpha therapy is commonly used in Behçet uveitis. Interferon treatment in various diseases have also been observed causing certain autoimmune diseases such as vitiligo because of its immunomodulatory activity. The association between IFN therapy and vitiligo has been reported in the literature. We report a 21-year-old man with BD in whom vitiligo occurred during IFN treatment. To the best of our knowledge, this is the first reported case of such an association.
format Online
Article
Text
id pubmed-3431079
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34310792012-09-05 Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease Guney, Esra Akcali, Gulunay Akcay, Betul Ilkay Unlu, Cihan Erdogan, Gurkan Bozkurt, Tahir Kansu Bayramlar, Huseyin Case Rep Med Case Report Behçet's disease (BD) and vitiligo are diseases of unknown etiology. Interferon (IFN) alpha therapy is commonly used in Behçet uveitis. Interferon treatment in various diseases have also been observed causing certain autoimmune diseases such as vitiligo because of its immunomodulatory activity. The association between IFN therapy and vitiligo has been reported in the literature. We report a 21-year-old man with BD in whom vitiligo occurred during IFN treatment. To the best of our knowledge, this is the first reported case of such an association. Hindawi Publishing Corporation 2012 2012-08-16 /pmc/articles/PMC3431079/ /pubmed/22952476 http://dx.doi.org/10.1155/2012/387140 Text en Copyright © 2012 Esra Guney et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Guney, Esra
Akcali, Gulunay
Akcay, Betul Ilkay
Unlu, Cihan
Erdogan, Gurkan
Bozkurt, Tahir Kansu
Bayramlar, Huseyin
Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease
title Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease
title_full Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease
title_fullStr Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease
title_full_unstemmed Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease
title_short Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease
title_sort vitiligo in a patient treated with interferon alpha-2a for behçet's disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431079/
https://www.ncbi.nlm.nih.gov/pubmed/22952476
http://dx.doi.org/10.1155/2012/387140
work_keys_str_mv AT guneyesra vitiligoinapatienttreatedwithinterferonalpha2aforbehcetsdisease
AT akcaligulunay vitiligoinapatienttreatedwithinterferonalpha2aforbehcetsdisease
AT akcaybetulilkay vitiligoinapatienttreatedwithinterferonalpha2aforbehcetsdisease
AT unlucihan vitiligoinapatienttreatedwithinterferonalpha2aforbehcetsdisease
AT erdogangurkan vitiligoinapatienttreatedwithinterferonalpha2aforbehcetsdisease
AT bozkurttahirkansu vitiligoinapatienttreatedwithinterferonalpha2aforbehcetsdisease
AT bayramlarhuseyin vitiligoinapatienttreatedwithinterferonalpha2aforbehcetsdisease

Ejemplares similares